Studies of selected phenyltropanes at monoamine transporters

Drug and Alcohol Dependence

Volumn 56, Issue 1, 1999, Pages 9-15

  Kuhar, Michael J ^a   McGirr, Kathleen M ^a   Hunter, Richard G ^a   Lambert, Philip D ^a   Garrett, Bridgette E ^a   Carroll, F Ivy ^b  

^a EMORY UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

3 Phenyltropane analogues; Cocaine; Medication; Monoamine transporters; Selected phenyltropanes

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; ALPHA ADRENERGIC RECEPTOR; CARRIER PROTEIN; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; NORADRENALIN; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER; TROPANE DERIVATIVE;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BRAIN; CAUDATE NUCLEUS; CEREBELLUM CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; RHOMBENCEPHALON; SPECIES DIFFERENCE;

ADULT; AGED; ANIMALS; BINDING, COMPETITIVE; CARRIER PROTEINS; CAUDATE NUCLEUS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; RHOMBENCEPHALON; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYMPORTERS; TROPANES;

MACACA MULATTA;

EID: 0032984327     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00005-8     Document Type: Article

References (34)

1. Bennett, B.A., Wichems, C.H., Hollingsworth, C.K., Davies, H.M.L., Thornley, C., Sexton, Childers, S.R., 1995. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain. J. Pharmacol. Exp. Ther. 272, 1176-1186.
2. Blough, B.E., Abraham, P., Mills, A.C., Lewin, A.H., Boja, J.W., Scheffel, U., Kuhar, M.J., Carroll, F.I., 1997. 3β-(4-ethyl-3-iodophenyl)nortropane-2β-carboxylic acid methyl ester as a high-affinity selective ligand for the serotonin transporter. J. Med. Chem. 40, 3861-3864.
3. Boja, J.W., Cline, E.J., Carroll, F.I., Lewin, A.H., Philip, A., Dannals, R., Wong, D., Scheffel, U., Kuhar, M.J., 1992. High potency cocaine analogs: neurochemical, imaging, and behavioral studies. Ann. New York Acad. Sci. 654, 282-291.
4. Carroll, F.I., Lewin, A.H., Boja, J.W., Kuhar, M.J., 1992a. Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. J. Med. Chem. 35, 969-981.
5. Carroll, F.I., Abraham, P., Lewin, A.H., Parham, K., Boja, J.W., Kuhar, M.J., 1992b. Isopropyl and phenyl esters of 3β-(4-substituted phenyl)tropane-2β-carboxylic acids. Potent and selective compounds for the dopamine transporter. J. Med. Chem. 35, 2497-2500.
6. Carroll, F.I., Kotian, P., Gray, J.L., Abraham, P., Kuzemko, M.A., Lewin, A.H., Boja, J.W., Kuhar, M.J., 1993. β-(4′-chlorophenyl)tropane-2β-carboxamides and cocaine amide analogues. New high affinity and selective compounds for the dopamine transporter. Med. Chem. Res. 3, 468-472.
7. Carroll, F.I., Kotian, P., Dehghani, A., Gray, J.L., Kuzemko, M.A., Parham, K.A., Abraham, P., Lewin, A.H., Boja, J.W., Kuhar, M.J., 1995. Cocaine and 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid ester and amide analogues. New high-affinity and slective compounds for the dopamine transporter. J. Med. Chem. 38 (2), 379-388.
8. Carroll, F.I., Lewin, A.H., Kuhar, M.J., 1997. Dopamine Transporter Uptake Blockers. In: Reith, M.E.A. (Ed.), Neurotransmiter Transporters: Structure, Function and Regulation. Humana Press, Totowa, NJ, pp. 263-295.
9. Clarke, R.L., Daum, S.J., Gambino, A.J., Aceto, M.D., Pearl, J., Levitt, M., Cumiskey, W.R., Bogado, E.F., 1973. Compounds affecting the central nervous system. 4. 3-β-phenyltropane-2-carboxylic esters and analogs. J. Med. Chem. 16, 1260-1267.
10. Davies, H.M.L., Saikali, E., Secton, T., Childers, S.R., 1993. Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat stratum. Eur. J. Pharmcol. 244, 93-97.
11. Deutsch, H., Shi, Q., Schweri, M., 1996. Synthesis and pharmacology of potential cocaine antagonists: SAR studies of aromatic ring substituted methylphenidate analogs. J. Med. Chem. 39, 1201-1209.
12. Froimowitz, M., Deutsch, H.M., Shi, Q., Wu, K.-M., Glaser, R., Adin, I., George, C., Schweri, M.M., 1997. Further evidence for a dopamine reuptake pharmacophore. The effect of N-methylation on threo-methylphenidate and analogs. Bioorg. Med. Chem. Lett. 7, 1213-1218.
13. Giros, B., Caron, M.G., 1993. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14, 43-49.
14. Goodman, M.M., Kung, M.-P., Kabalka, G.W., Kung, H.F., Switzer, R., 1994. Synthesis and characterization of radio-iodinated N - (3 - iodopropen - 1 - yl) - 2β - carbomethoxy - 3β - (4-chlorophenyl)tropanes: potential dopamine reuptake site imaging agents. J. Med. Chem. 37, 1535-1542.
15. Kline, R.H. Jr., Wright, J., Fox, K.M., Eldefrawi, M.E., 1990. Synthesis of 3-arylecgonine analogues as inhibitors of cocaine binding and dopamine uptake. J. Med. Chem. 33, 2024-2027.
16. Koob, G.F., Bloom, F.E., 1988. Cellular and molecular mechanisms of drug dependence. Science 242, 714-723.
17. Kozikowski, A.P., Roberti, M., Xiang, L., Bergmann, J.S., Callahan, P.M., Cunningham, K.A., Johnson, K.M., 1992. Structure-activity relationship studies of cocaine: replacement of the C-2 ester group by vinyl argues against H-bonding and provides an esterase-resistant, high affinity cocaine analog. J. Med. Chem. 35, 4764-4766.
18. Kuhar, M.J., 1997. Developing medications for drug abusers. In: Harnessing Technology to Support the National Drug Control Strategy. Proceedings of the 1997 Office of National Drug Control Policy (ONDCP) International Technology Symposium, Chicago, IL, August 18-21, pp. 2-3-2-4.
19. Kuhar, M.J., Ritz, M.C., Boja, J.W., 1991. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14 (7), 299-302.
20. Matecka, D., Lewis, D., Rothman, R.B., Dersch, C.M., Wojnicki, F.H., Glowa, J.R., DeVries, A.C., Pert, A., Rice, K.C., 1997. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis (4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)pi perazines (GBR 129435 and GBR 12909) as high-affinity dopamine reuptake inhibitors. J. Med. Chem. 40 (5), 705-716.
21. Meltzer, P.C., Liang, A.Y., Brownell, A.-L., Elmaleh, D.R., Madras, B.K., 1992. Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging. J. Med. Chem. 36 (7), 855-863.
22. Meltzer, P.C., Liang, A.Y., Madras, B.K., 1994. The discovery of an unusually selective and novel cocaine analog: difluoropine. Synthesis and inhibition of binding at cocaine recognition sites. J. Med. Chem. 37, 2001-2010.
23. Nader, M.A., Grant, K.A., Davies, H.M.L., Mach, R.H., Childers, S.R., 1997. The reinforcing and discriminative stimulus effects of the novel cocaine analog 2β-propanoyl-3β-(4-tolyl)-tropane in rhesus monkeys. J. Pharm. Exp. Ther. 280, 541-550.
24. Newman, A.H., Allen, A.C., Ezenwasser, S., Katz, J.L., 1994. Novel 3α(diphenylmethoxy)-tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J. Med. Chem. 37, 2258-2261.
25. Ritz, M.C., Lamb, R.J., goldberg, S.R., Kuhar, M.J., 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223.
26. Rothman, R.B., 1990. High affinity dopamine reuptake inhibitors as potential cocaine antagonists: a strategy for drug development. Life Sci. 46, 17-21.
27. 3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists. Life Sci. 53, 267-272.
28. Simoni, D., Stoelwinder, J., Kozikowski, A.P., Johnson, K.M., Bergmann, J.S., Ball, R.G., 1993. Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: discovery of a weak cocaine "antagonist". J. Med. Chem. 36, 3975-3977.
29. Slusher, B.S., Tiffany, C.W., Olkowski, J.L., Jackson, P.F., 1997. Use of identical assay conditions for cocaine analog binding and dopamine uptake to identify potential cocaine antagonists. Drug Alcohol Depend. 48, 43-50.
30. Stathis, M., Scheffel, U., Lever, S.Z., Boja, J.W., Carroll, F.I., Kuhar, M.J., 1995. Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology 119, 376-384.
31. van der Zee, P., Koger, H.S., Gootjes, J., Hespe, W., 1980. Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15, 363-370.
32. Volkow, N.D., Wang, G.-J., Fischman, M.W., Foltin, R.W., Fowler, J.S., Abumrad, N.N., Vitkun, S., Logan, J., Gatley, S.J., Pappas, N., Hitzemann, R., Shea, C.E., 1997. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386, 827-830.
33. Wang, S., Gao, Y., Laruelle, M., Baldwin, R.M., Scanley, B.E., Innis, R.B., Neumeyer, J.L., 1993. Enantioselectivity of cocaine recognition sites: binding of (1S)- and (1R)-2β-carbomethoxy-3β-(4-iodophenyl)tropane (β-CIT) to monoamine transporters. J. Med. Chem. 36, 1914-1917.
34. Wise, R.A., Bozarth, M.A., 1987. A psychomotor stimulant theory of addiction. Psychol. Rev. 94, 469-492.